Johnson Johnson

Showing of 1 - 20 from 59 results
Johnson Johnson - Total results - 59
Western warnings tarnish the COVID-19 vaccines that the world desperately needs
World

Western warnings tarnish the COVID-19 vaccines that the world desperately needs

Skittishness over the AstraZeneca and Johnson & Johnson vaccines, analysts fear, could stoke demand for Russian- and Chinese-made shots, about which far less is known

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs
science

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs

If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year.

AstraZeneca COVID-19 shot found 79% effective in adults in long-awaited US study
science

AstraZeneca COVID-19 shot found 79% effective in adults in long-awaited US study

The independent safety monitors found no serious side effects, including an increased risk of blood clots found in an EU study.

Moderna kicks off COVID-19 vaccine trials in children aged 6 months to under 12 years
World

Moderna kicks off COVID-19 vaccine trials in children aged 6 months to under 12 years

"This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population," said CEO Stephane Bancel in a statement

Ebola survivor infected years ago may have started new outbreak in Guinea, claim researchers
World

Ebola survivor infected years ago may have started new outbreak in Guinea, claim researchers

The survivor harboured the virus for at least five years and then transmitted it via semen to a sex partner, researchers reported in articles published in Science and Stat. Until now, the longest the ebola virus had been known to persist in a survivor was 500 days

With eyes on China, Quad nations launch 1 bn vaccine plan, project grouping as 'vital arena for cooperation'
World

With eyes on China, Quad nations launch 1 bn vaccine plan, project grouping as 'vital arena for cooperation'

PM Narendra Modi said the first Quad summit shows that the group has come of age and will now remain an important pillar of stability in the region. It was attended by US president Joe Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga

J&J chief scientist Paul Stoffels explains 'secret sauce' of its single-dose COVID-19 shot
science

J&J chief scientist Paul Stoffels explains 'secret sauce' of its single-dose COVID-19 shot

Independent of region, virus variant, or age, the vaccine protects against severe disease, death and hospitalization, Stoffers said.

EU drug regulator approves J&J's one-shot COVID-19 vaccine for adults
World

EU drug regulator approves J&J's one-shot COVID-19 vaccine for adults

The European Medicines Agency said it was recommending the COVID-19 jab for those over 18 “after a thorough evaluation” found it met the criteria for efficacy, safety and quality

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s
World

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s

JnJ's vaccine appears to be less prone than Pfizer-BioNTech's and Moderna's, to trigger the kinds of side effects that require monitoring.

US gets third COVID-19 vaccine as FDA approves Johnson & Johnson's one-dose shot
World

US gets third COVID-19 vaccine as FDA approves Johnson & Johnson's one-dose shot

The FDA said J&J's vaccine offers strong protection against serious illness, hospitalisations, and death. The company has said it expects to deliver 20 million doses to the US by the end of March

Johnson & Johnson's single-shot vaccine highly effective in preventing severe COVID-19, announces US FDA
World

Johnson & Johnson's single-shot vaccine highly effective in preventing severe COVID-19, announces US FDA

In large clinical trials, the vaccine's efficacy against severe COVID-19 disease was 85.9 percent in the US, 81.7 percent in South Africa, and 87.6 percent in Brazil

Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close
World

Pfizer, Moderna, Astrazeneca, Bharat Biotech, other COVID-19 vaccines in use or getting close

The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested.

Johnson & Johnson one-dose COVID-19 shot offers strong protection, fuels concern about variants
World

Johnson & Johnson one-dose COVID-19 shot offers strong protection, fuels concern about variants

A single-dose vaccine is a big advantage when most countries are struggling to get shots in arms more quickly.

COVID-19 vaccine delivery to poor countries will start in early 2021, says WHO chief
World

COVID-19 vaccine delivery to poor countries will start in early 2021, says WHO chief

Almost two billion doses of candidate vaccines have been secured for the Covax facility, created by the UN health agency, to ensure fair access

Moderna to file today for US, EU clearance for emergency use of COVID-19 vaccine
World

Moderna to file today for US, EU clearance for emergency use of COVID-19 vaccine

Moderna, which created its shots with the US National Institutes of Health, said it got the final needed results over the weekend that suggest the vaccine is more than 94 percent effective

Planes, dry ice, pharmacies: The many logistical challenges in distributing COVID-19 vaccines
World

Planes, dry ice, pharmacies: The many logistical challenges in distributing COVID-19 vaccines

Stamping out the coronavirus is a distinctly new challenge due to three factors: the short time frame for inoculating a huge number of people, the fact that most vaccines will require two doses, and the very low temperature at which some of the vaccines must be stored

After Johnson & Johnson, US pharma company Eli Lilly’s halts COVID-19 antibody treatment over safety concerns
World

After Johnson & Johnson, US pharma company Eli Lilly’s halts COVID-19 antibody treatment over safety concerns

Medical experts note that pauses in large clinical trials of coronavirus are not uncommon. They said its possible the bad reaction could be the result of an unrelated illness, and not the drug itself

Johnson & Johnson halts COVID-19 vaccine trial after participant develops 'unexplained illness'
World

Johnson & Johnson halts COVID-19 vaccine trial after participant develops 'unexplained illness'

The J&J Phase 3 trial had started recruiting participants in September 2020, with a goal of enrolling up to 60,000 volunteers across more than 200 sites in the US and around the world

Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine
News & Analysis

Some COVID-19 vaccine makers have declared their intentions to profit from the vaccine

Experts point out that the global distribution of a vaccine is necessary since none of us is safe until all of us are safe.

COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests
World

COVID-19 vaccine: Potential coronavirus vaccine candidate from China shows promise in animal tests

More than 100 potential COVID-19 vaccines are in various stages of development around the world.